Truly Labs AB

Truly Labs AB is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1

Countries 1

Type of company: Small business

Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.

Chemistry, Manufacturing and Controls (CMC) Request Chemistry, Manufacturing and Controls services

Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
Pharmacokinetic Studies Design a study that observes the time course of drug absorption, distribution, metabolism, and excretion, as means to test the safety and effective therapeutic management of drugs in an individual patient.

Assay Development Consulting Request consultant services measuring the activity of a drug or biochemical in an organism or organic sample.
Large Molecule Drug Development Consulting Develop large molecule drugs and complex biologics that have a therapeutic effect.
Small Molecule Drug Development Consulting Request consulting services related to small molecule development.
Toxicology Consulting Use models to assess acute and sub-acute toxicity as well as chronic and sub-chronic toxicity.

Assay Development Construct or create new assays or modify existing ones.
In Vitro Assay Development Develop innovative assay and screening methods outside a living organism to enable a wide range of pre-clinical activities.

Show all 25 services 12 more

Fibroblast Growth Factor Receptor (FGFR) Assays Use biochemical, cell based or in vivo assays to measure FGF receptor activity.
Immuno-oncology Assays Use biochemical, cell based or in vivo assays to measure the activity of immuno-therapy targets.
Immuno-oncology Targets Develop drugs that take advantage of the immune system to target cancer cells.
In Vitro Oncology Models Use cell-based and biochemical models of cancer.
Programmed Cell Death-1 (PD-1) Assays Use biochemical, cell based or in vivo assays to measure PD-1 receptor activity.
Target Identification Identify the target(s) of a biologically active substance.

Show all 8 in In Vitro Pharmacology 2 more

Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.
Vascular Endothelial Growth Factor Receptor (VEGFR) Assays Use biochemical, cell based or in vivo assays to measure VEGF receptor activity.

Cachexia Models Measure therapeutic endpoints in animal models of cachexia.
Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
Oncology Xenografts Xenografts derived from oncological samples.

Human Dendritic Cell (hDC) Model Test and validate the immune-modulating compounds in DC immune pathway models.

Work with Truly Labs AB on Scientist.com

For prices, more details, or to contact Truly Labs AB, visit Scientist.com.